Reshma Kewalramani - CEO & President, Vertex Pharmaceuticals Inc / Ma
As of February 28, 2022
Reshma Kewalramani Net Worth
- Net worth is estimated to be at least $14.89M
- Owns at least 73,754 units of Vertex Pharmaceuticals Inc / Ma stock
- Sold an estimated value of $12.78M in the last 4 years at Vertex Pharmaceuticals Inc / Ma
Reshma Kewalramani Trading
- Largest purchase of shares was 10,000 units , worth over $1.96M on August 23, 2021
- Largest sale of shares was 6,532 units , worth over $1.54M on February 26, 2020
- In total has made about 24 transactions over 4 years
- Usually trades in February, with the busiest year in 2019
Reshma Kewalramani
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
Reshma Kewalramani Mailing Address
- Mailing address is C/o Vertex Pharmaceuticals, Inc. 50 Northern Avenue Boston MA 02210 MA
Vertex Pharmaceuticals Inc / Ma Insider Trading
- The most recent transaction was 45 units sold on May 18, 2022 by Bastiano Sanna worth over $11.38K
- In the last 19 years, insiders at Vertex Pharmaceuticals Inc / Ma sold an estimated value of $1.61B and bought an estimated value of $522.29M
- The most active traders are Joshua Boger, Director, Paul Silva, SVP & Chief Accounting Officer, and Amit Sachdev, EVP
- Insider trading is most common in February, with the busiest year in 2015
VERTEX PHARMACEUTICALS INC / MA Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |